Meeting Overview | On behalf of Christos Markopoulos, MD, meeting chairman, we are pleased to invite you to the Expert Practice℠ in Breast Cancer meeting in Athens, Greece, on 17 April 2010.
During this case-based meeting, leaders in the field will discuss, in an interactive format, clinical issues encountered daily by practicing oncologists.
Delegates will receive:
• Round trip economy air or train transportation
• Hotel accommodation will be offered on Friday 16 April
• Registration includes: Welcome reception, dinner, coffee break and lunch
|
Meeting Venue | Hilton Athens
46, Vas. Sofias Avenue
Athens, Greece
|
Faculty | Chair:
Christos Markopoulos, MD
Athens University Medical School
Athens, Greece
Faculty:
Javier Cortés, MD
Vall d’Hebron Hospital
Barcelona, Spain
Alessandra Gennari, MD, PhD
Galliera Hospital
Genoa, Italy
Daniel Rea, MD, PhD
University of Birmingham
Birmingham, United Kingdom
|
 Agenda |
|
Friday, 16 April 2010
|
| 20.00 |
|
Reception followed by buffet dinner |
| Saturday, 17 April 2010 |
| 08.00 |
|
Breakfast |
| 09.00 |
|
Welcome, introduction, and demographics
Bojana Pajk, MD
Christos Markopoulos, MD |
| 09.15 |
|
Keynote Lecture
Unanswered questions in endocrine therapy of breast cancer in 2010
Christos Markopoulos, MD
|
| 09.45 |
|
Case #1
Evaluating the options for triple-negative breast cancer
Alessandra Gennari, MD, PhD
|
| 10.15 |
|
Questions and answers |
| 10.20 |
|
Case #2
Optimizing adjuvant endocrine therapy for postmenopausal patients
Daniel Rea, MD, PhD
|
| 10.50 |
|
Questions and answers |
| 10.55 |
|
Break |
| 11.15 |
|
Case #3
HER2-negative metastatic breast cancer previously treated with an anthracycline and taxane: What’s the best approach?
Javier Cortés, MD
|
| 11.45 |
|
Questions and answers |
| 11.50 |
|
Case #4
Inflammatory breast cancer: Treatment strategies
Alessandra Gennari, MD, PhD
|
| 12.20 |
|
Questions and answers |
| 12.25 |
|
Case #5
The use of gene expression profiles in endocrine-responsive early breast cancer
Christos Markopoulos, MD
|
| 12.55 |
|
Questions and answers |
| 13.00 |
|
Lunch |
| 14.00 |
|
Clinical opinion poll questions: Challenging the experts
Faculty Panel
|
| 14.30 |
|
Case #6
Endocrine-responsive breast cancer with bone metastases: What are the treatment options?
Daniel Rea, MD, PhD
|
| 15.00 |
|
Questions and answers |
| 15.05 |
|
Case #7
Brain metastases in HER2-positive breast cancer: Opportunities and challenges
Javier Cortés, MD
|
| 15.35 |
|
Questions and answers |
| 15.40 |
|
Concluding remarks |
|

|